Mette Kirstine Agger

Ms. Agger serves on numerous boards of both private and public companies, including KLIFO, a pharmaceutical consulting company, Lexeo, a gene therapy company targeting orphan diseases, DYSIS Medical, a womens health medtech company, and Psioxus, a tumor re-engineering company, ScPharmaceuticals, focused on novel solutions for out-patient care, and C.V Obel A/S, an investment company Ms. Agger has served 12 years from Sept 2009 to April 2022 as a managing partner of Lundbeckfonden Ventures, a life science venture fund, and as part of the management at Lundbeckfonden. Prior to that, Ms. Agger co-founded 7TM Pharma A/S, a biotech company engaged in therapeutic drug discovery and development, in 2000, and served as its chief executive officer from founding to 2009. Prior to founding 7TM Pharma, Ms. Agger was part of the management team of NeuroSearch A/S, a former drug research and development company. Ms. Agger graduated with an M.Sc. in Biology from the University of Copenhagen and has an M.B.A. from Henley Business School University of Reading.